Welcome to the 11th Clinical Biomarkers & World CDx Boston

Precision medicine is now well and truly the gold standard of therapeutic development. With investment pouring into the industry, it’s never been more critical to ensure your candidates are clinically effective and commercially ready.

Stay ahead at the 11th Clinical Biomarkers & World CDx Boston Summit by informing early biomarker translation and assay validation, clinical strategy and decision-making, market access and regulatory preparations and drug-Dx co-development strategies.

Returning with world-class insights and data-driven advancements, the Clinical Biomarkers & World CDx Boston Summit will help you:

  • Deliver market-dominating therapies through robust partnership and commercial strategies
  • Advance the next break-through candidates with exciting translational and validation approaches
  • Inform your clinical decisions and deliver improved patient outcomes with novel lessons from biopharma and the clinic